Sep 302016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced that Mark J.… => Read more

Chiasma appoints Mark Fitzpatrick to its Board of Directors as CEO

From:: Chiasma appoints Mark Fitzpatrick to its Board of Directors as CEO

Sorry, the comment form is closed at this time.

%d bloggers like this: